Mesecar Official

His work includes developing non-covalent, selective inhibitors designed to work against multiple emerging coronavirus strains, including MERS-CoV.

He specializes in determining high-resolution 3D structures of enzymes (such as 3CLpro and PLpro) in coronaviruses and cancer to design selective drugs. mesecar

He is the Robert Wallace Miller Director of the Purdue Institute for Cancer Research , where he leads efforts in developing novel cancer therapies, diagnostics, and targeting cancer at the cellular level. He is involved in translational research to turn

He is involved in translational research to turn basic molecular findings into commercial drugs for cancer and Alzheimer's disease. His work includes developing non-covalent

Dr. Mesecar's team played a crucial role in identifying the antiviral X77 , which was effective against the SARS-CoV-2 main protease ( Mprocap M raised to the p r o power